Metronomic Therapy in Metastatic Breast Cancer.
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: bevacizumab, Paclitaxel|BIOLOGICAL: Bevacizumab, Cyclophosphamide, Capecitabine
Sponsor: Swiss Group for Clinical Cancer Research